Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 278Lung Neoplasms 257Small Cell Lung Carcinoma 82Breast Neoplasms 59Mesothelioma, Malignant 49Adenocarcinoma of Lung 43Pancreatic Neoplasms 37Colonic Neoplasms 37Neoplasms 32Prostatic Neoplasms 30Ovarian Neoplasms 28Esophageal Neoplasms 26Neoplasm Metastasis 24Mesothelioma 24Melanoma 24Adenocarcinoma, Bronchiolo-Alveolar 24Stomach Neoplasms 22Colorectal Neoplasms 22Carcinoma, Renal Cell 22Rectal Neoplasms 20Urinary Bladder Neoplasms 18Uterine Cervical Neoplasms 17Squamous Cell Carcinoma of Head and Neck 17Carcinoma, Hepatocellular 17Brain Neoplasms 17Lymphoma, Non-Hodgkin 16Carcinoma, Ovarian Epithelial 16Thymoma 15Salivary Gland Neoplasms 15Lymphoma 15

Interventions

Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lymphangioleiomyomatosis × Thoracic × Clear all
NCT00005906 2010-04-30

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
4 enrolled 8 charts
Thoracic

Ascites, Chylous Ascites, Chylothorax, Lymphangiomyoma, Pleural Effusion, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡